(S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (VBG growing) (NN need)) (PP (IN for) (NP (NP (ADJP (NN fast) (CC and) (JJ accurate)) (NNS methods)) (PP (IN for) (S (VP (VBG testing) (NP (JJ developmental) (NN neurotoxicity)) (PP (IN across) (NP (JJ several) (NN chemical) (NN exposure) (NNS sources)))))))))) (. .))
(S (NP (NP (JJ Current) (NNS approaches)) (, ,) (PP (JJ such) (IN as) (NP (NP (ADJP (IN in) (NN vivo)) (NN animal) (NNS studies)) (, ,) (CC and) (NP (NP (NNS assays)) (PP (IN of) (NP (ADJP (NN animal) (CC and) (JJ human)) (NN primary) (NN cell) (NNS cultures)))))) (, ,)) (VP (VBP suffer) (PP (IN from) (NP (NP (NNS challenges)) (VP (VBN related) (PP (TO to) (NP (NP (NN time)) (, ,) (NP (NN cost)) (, ,) (CC and) (NP (NP (NN applicability)) (PP (TO to) (NP (JJ human) (NN physiology)))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB previously)) (VP (VBD demonstrated) (NP (NP (NN success)) (S (VP (VBG employing) (NP (NN machine) (VBG learning)) (S (VP (TO to) (VP (VB predict) (NP (JJ developmental) (NN neurotoxicity)) (S (VP (VBG using) (NP (NP (NN gene) (NN expression) (NNS data)) (VP (VBN collected) (PP (IN from) (NP (NP (JJ human) (CD 3D) (NN tissue) (NNS models)) (VP (VBN exposed) (PP (TO to) (NP (JJ various) (NNS compounds))))))))))))))))) (. .))
(S (S (NP (DT The) (CD 3D) (NN model)) (VP (VBZ is) (ADJP (RB biologically) (JJ similar) (PP (TO to) (S (VP (VBG developing) (NP (JJ neural) (NNS structures)))))))) (, ,) (CC but) (S (NP (PRP$ its) (NN complexity)) (VP (NNS necessitates) (NP (NP (JJ extensive) (NN expertise) (CC and) (NN effort)) (SBAR (S (VP (TO to) (VP (VB employ)))))))) (. .))
(S (PP (IN By) (S (ADVP (RB instead)) (VP (VBG focusing) (ADVP (RB solely)) (PP (IN on) (S (VP (VBG constructing) (NP (NP (DT an) (NN assay)) (PP (IN of) (NP (JJ developmental) (NN neurotoxicity)))))))))) (, ,) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (DT a) (NN simpler) (CD 2D) (NN tissue) (NN model)) (VP (MD may) (VP (VB prove) (ADJP (NN sufficient))))))) (. .))
(S (NP (PRP We)) (ADVP (RB thus)) (VP (VP (VBP compare) (NP (NP (DT the) (NN accuracy)) (PP (IN of) (NP (NP (JJ predictive) (NNS models)) (VP (VBN trained) (PP (IN on) (NP (NP (NNS data)) (PP (IN from) (NP (DT a) (CD 2D) (NN tissue) (NN model))))))))) (PP (IN with) (NP (NP (DT those)) (VP (VBN trained) (PP (IN on) (NP (NP (NNS data)) (PP (IN from) (NP (DT a) (CD 3D) (NN tissue) (NN model))))))))) (, ,) (CC and) (VP (VB find) (S (NP (DT the) (CD 2D) (NN model)) (VP (TO to) (VP (VB be) (ADJP (RB substantially) (JJR more) (NN accurate))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP find) (S (NP (DT the) (CD 2D) (NN model)) (VP (TO to) (VP (VB be) (JJR more) (JJ robust) (PP (IN under) (NP (JJ stringent) (NN gene) (VBN set) (NN selection))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (CD 3D) (NN model)) (VP (NNS suffers) (NP (JJ substantial) (NN accuracy) (NN degradation))))))))) (. .))
(S (SBAR (IN While) (S (NP (DT both) (NNS approaches)) (VP (VBP have) (NP (NNS advantages) (CC and) (NNS disadvantages))))) (, ,) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (PRP$ our) (VBD described) (CD 2D) (NN approach)) (VP (MD could) (VP (VB be) (NP (DT a) (JJ valuable) (NN tool)) (PP (IN for) (NP (NN decision) (NNS makers))) (SBAR (WHADVP (WRB when)) (S (VP (VBG prioritizing) (NP (NN neurotoxicity) (NN screening)))))))))) (. .))
